How I assess comorbidities before hematopoietic cell transplantation - ScienceDirect
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect
Expanded Comorbidity Definitions Improve Applicability of the Hematopoietic Stem Cell Transplantation-Comorbidity Index for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation ...
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for ...
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect
Presentazione standard di PowerPoint
Disease-Free Survival Calculator
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT - ScienceDirect
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
Comparing Hematopoietic Cell Transplant versus Other Treatments for Adults with Acute Myeloid Leukemia - NCBI Bookshelf
Sisteme vizuale | Komax
Presentazione standard di PowerPoint
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect
Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome - Biology of Blood and Marrow Transplantation
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older | Bone Marrow Transplantation
Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis | Request PDF